Skip to search formSkip to main contentSkip to account menu

BRL 28500

Known as: BRL-28500 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (6)

Clavulanate / TicarcillinClavulanic AcidsEnzyme InhibitorsTicarcillin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
BRL 28500 (Clavulanic acid/Ticarcillin) の腹腔内感染症, 胆道感染症に対する臨床試験
: Clinical studies have been conducted on BRL 28500 (a formulation containing 15 parts ticarcillin (TIPC) plus 1 part clavulanic… 
1987
1987
[Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
Clinical studies have been conducted on BRL 28500 (a formulation containing 15 parts ticarcillin (TIPC) plus 1 part clavulanic… 
1986
1986
T-2588の in vitro および in vivo 抗菌作用について
1986
1986
BRL 28500 (Clavulanic acid-Ticarcillin) にかんする研究
1986
1986
BRL 28500 (Clavulanic acid-Ticarcillin) の母・児・羊水移行性の検討
1986
1986
BRL 28500 (Clavulanic acid-Ticarcillin) の臨床使用経験
1986
1986
BRL 28500 (Clavulanic acid-Ticarcillin) の抗菌作用およびクラブラン酸の生菌中β-lactamaseに対する阻害効果について
1986
1986
LABORATORY AND CLINICAL STUDIES ON BRL 28500 (CLAVULANIC ACID-TICARCILLIN)
1986
1986
BRL 28500 (Clavulanic acid-Ticarcillin) の抗菌作用
1986
1986
BRL 28500 (Clavulanic acid-Ticarcillin) の基礎的・臨床的検討
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)